Vitamin D3 and calcipotriol decrease extracellular plasminogen activator activity in cultured keratinocytes

Journal of Investigative Dermatology

Volumn 101, Issue 5, 1993, Pages 706-712

  Koli, Katri ^a   Keski Oja, Jorma ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

pericellular proteolysis; plasminogen activator; plasminogen activator inhibitor 1 TGF

Indexed keywords

CALCIPOTRIOL; CALCITRIOL; COLECALCIFEROL; DERMATOLOGICAL AGENT; DRUG DERIVATIVE; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UROKINASE; EPIDERMAL GROWTH FACTOR; LEXACALCITOL; PHORBOL ESTER; SEOCALCITOL; TISSUE PLASMINOGEN ACTIVATOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; DRUG EFFECT; ENZYMOLOGY; EXTRACELLULAR MATRIX; HUMAN; KERATINOCYTE; METABOLISM; MOUSE; MOUSE STRAIN; ANIMAL CELL; CONTROLLED STUDY; HUMAN CELL; INFANT; MALE; PRIORITY JOURNAL;

ANIMAL; CALCITRIOL; CELLS, CULTURED; CHOLECALCIFEROL; DERMATOLOGIC AGENTS; EXTRACELLULAR MATRIX; HUMAN; KERATINOCYTES; MICE; MICE, INBRED BALB C; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATORS; PROTEINS; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; TETRADECANOYLPHORBOL ACETATE; TRANSFORMING GROWTH FACTOR BETA; URINARY PLASMINOGEN ACTIVATOR;

EID: 0027332481     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12371680     Document Type: Article

References (40)

1. 3: enhancement of TGFβ expression and decrease of plasminogen activator activity (abstr) J Cell Biochem Suppl 16 1992 124
2. Norman A.W. Roth J. Orci L. The vitamin D endocrine system: steroid metabolism, hormone receptors, and biological response (calcium binding proteins) Endocr Rev 3 1982 331 366
3. 3 receptors in human carcinomas: a pilot study Cancer Res 51 1991 2021 2024
4. 3 analogues: a novel class of potent regulators of cell growth and immune responses Biochem Pharmacol 42 1991 1569 1575
5. 3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia Endocrinology 129 1991 832 837
6. 3 treatment in psoriasis vulgaris Br J Dermatol 115 1986 421 429
7. Binderup L. Bramm E. Effects of a novel vitamin D analogue MC 903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo Biochem Pharmacol 37 1988 889 895
8. 3 and skin diseases Arch Dermatol Res 284 1992 30 36
9. 3 Endocrinology 113 1983 1950 1957
10. 3 on the morphology and biochemical differentiation of cultured human keratinocytes grown in serum-free conditions J Invest Dermatol 86 1986 709 714
11. 3 analogue stimulates terminal differentiation and inhibits proliferation of cultured human keratinocytes Arch Dermatol Res 282 1990 164 167
12. 3 and calcipotriol enhance the secretion of transforming growth factor-β1 and -β2 in cultured murine keratinocytes Growth Factors 8 1993 153 163
13. Grendahl-Hansen J. Ralfkiær E. Nielsen L.S. Kristensen P. Frentz G. Dane K. Immunohistochemical localization of urokinase-type and tissue-type plasminogen activators in psoriatic skin J Invest Dermatol 88 1987 28 32
14. Baird J. Lazarus G.S. Belin D. Vasalli J-D. Busso N. Gubler P. Jensen P.J. mRNA for tissue-type plasminogen activator is present in lesional epidermis from patients with psoriasis, pemphigus, or bullous pemphigoid, but is not detected in normal epidermis J Invest Dermatol 95 1990 548 552
15. Saksela O. Plasminogen activation and regulation of pericellular proteolysis Biochim Biophys Acta 823 1985 35 65
16. Laiho M. Keski-Oja J. Growth factors in the regulation of pericellular proteolysis: a review Cancer Res 49 1989 2533 2553
17. Keski-Oja J. Koli K. Enhanced production of plasminogen activator activity in human and murine keratinocytes by transforming growth factor-β1 J Invest Dermatol 99 1992 193 200
18. Stephens R. Pöllänen J. Tapiovaara H. Leung K-C. Sim P-S. Salonen E-M. Renne E. Behrendt N. Dane K. Vaheri A. Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants J Cell Biol 108 1989 1987 1995
19. Calverley M.J. Synthesis of MC 903, a biologically active vitamin D analogue Tetrahedron 43 1987 4609 4619
20. Saksela O. Radial cascinolysis in agarose: a simple method for detection of plasminogen activator activity in the presence of inhibitory substances and serum Anal Biochem 111 1981 276 282
21. Granelli-Piperno A. Reich E. A study of proteases and protease-inhibitor complexes in biological fluids J Exp Med 146 1987 223 234
22. Stoppelli M.P. Tacchetti C. Cubellis M.V. Cordi A. Hearing V.J. Catsani G. Apelli E. Blasi F. Autocrine saturation of pro-urokinase receptor on human A431 cells Cell 45 1986 675 684
23. Hedman K. Kurkinen M. Alitalo K. Vaheri A. Johansson S. Hook M. Isolation of the pericellular matrix of human fibroblast cultures J Cell Biol 81 1979 83 91
24. Chomczynski P. Sacci N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroforrn extraction Anal Biochem 162 1987 156 159
25. Maniatis T.E. Fritsch E.F. Sambrook J. Molecular Cloning, A Laboratory Manual Anal Biochem 1982 Cold Spring Harbor Laboratory Cold Spring Harbor, New York
26. Koli K. Lohi J. Hautanen A. Keski-Oja J. Enhancement of vitronectin expression in human HepG2 hepatoma cells by transforming growth factor-β1 Eur J Biochem 199 1991 337 345
27. Danø K. Nielsen L.S. Møller V. Engelhart M. Inhibition of a plasminogen activator from oncogenic virus-transformed mouse cells by rabbit antibodies against the enzyme Biochim Biophys Acta 630 1980 146 151
28. 3 J Cell Physiol 146 1991 94 100
29. Pöllänen J. Hedman K. Nielsen L. Danø K. Vaheri A. Ultrastructural localization of plasma membrane-associated urokinase-type plasminogen activator at focal contacts J Cell Biol 106 1988 87 95
30. Pillai S. Bikle D.D. Elias P.M. 1,25-dihydroxyvitamin D production and receptor binding in human keratinocytes varies with differentiation J Biol Chem 263 1988 5390 5395
31. Taipale J. Koli K. Keski-Oja J. Release of pericellular matrix-associated transforming growth factor-β1 of cultured fibroblasts and fibrosarcoma cells by plasmin and thrombin J Biol Chem 267 1992 25378 25384
32. Lyons R.M. Keski-Oja J. Moses H.L. Proteolytic activation of latent transforming growth factor-β from fibroblast-conditioned medium J Cell Biol 106 1988 1659 1665
33. Akhurst R.J. Fee F. Balmain A. Localized production of TGF-β mRNA in tumor promoter-stimulated mouse epidermis Nature 331 1988 363 365
34. Glick A.B. Danielpour D. Morgan D. Sporn M.B. Yuspa S.H. Induction and autocrine receptor binding of transforming growth factor-β2 during terminal differentiation of primary mouse kerarinocytes Mol Endocrin 4 1990 46 52
35. Grimaldi G. Di Fiore P. Locatelli E.K. Falco J. Blasi F. Modulation of urokinase plasminogen activator gene expression during the transition from quiescent to proliferative state in normal mouse cells Embo J 5 1986 855 861
36. Isseroff R.R. Fusenig N.E. Rifkin D.B. Plasminogen activator in differentiating mouse keratinocytes J Invest Dermatol 80 1983 217 222
37. Jensen P.J. John M. Baird J. Urokinase and tissue type plasminogen activators in human keratinocyte culture Exp Cell Res 187 1990 162 169
38. Grøndahl-Hansen J. Lund L.R. Ralfkiaer E. Ottevanger V. Danø K. Urokinase and tissue type plasminogen activators in keratinocytes during wound reepithelialization in vivo J Invest Dermatol 90 1988 790 795
39. Jensen P.J. Wheelock M.J. Regulation of urokinase plasminogen activator localization in keratinocytes by calcium ion and E-cadherin Exp Cell Res 202 1992 190 198
40. Ragno P. Estreicher A. Gos A. Wohlwend A. Belin D. Vassalli J-D. Polarized secretion of urokinase-type plasminogen activator by epithelial cells Exp Cell Res 203 1992 236 243